Interestingly, we recently showed that the expression of acid ceramidase (ASAH1), another key player in sphingolipid metabolism and signaling, was associated with significantly improved overall survival in estrogen receptor-negative endometrioid ovarian cancer. This evidence concerns the gene ESR1 and ovarian endometrioid adenocarcinoma.